annb0t
Top 20
MELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract manufacturing services to many c...
>>> Read more: Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
>>> Read more: Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
